• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgG1-Fc变体的物理稳定性比较:N-糖基化位点占据情况及Asn 297位点处Asp/Gln残基的影响

Physical stability comparisons of IgG1-Fc variants: effects of N-glycosylation site occupancy and Asp/Gln residues at site Asn 297.

作者信息

Alsenaidy Mohammad A, Okbazghi Solomon Z, Kim Jae Hyun, Joshi Sangeeta B, Middaugh C Russell, Tolbert Thomas J, Volkin David B

机构信息

Department of Pharmaceutical Chemistry, Macromolecule and Vaccine Stabilization Center, University of Kansas, Lawrence, Kansas 66047, USA.

出版信息

J Pharm Sci. 2014 Jun;103(6):1613-1627. doi: 10.1002/jps.23975. Epub 2014 Apr 16.

DOI:10.1002/jps.23975
PMID:24740840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4512762/
Abstract

The structural integrity and conformational stability of various IgG1-Fc proteins produced from the yeast Pichia pastoris with different glycosylation site occupancy (di-, mono-, and nonglycosylated) were determined. In addition, the physical stability profiles of three different forms of nonglycosylated Fc molecules (varying amino-acid residues at site 297 in the CH 2 domain due to the point mutations and enzymatic digestion of the Fc glycoforms) were also examined. The physical stability of these IgG1-Fc glycoproteins was examined as a function of pH and temperature by high-throughput biophysical analysis using multiple techniques combined with data visualization tools (three index empirical phase diagrams and radar charts). Across the pH range of 4.0-6.0, the di- and monoglycosylated forms of the IgG1-Fc showed the highest and lowest levels of physical stability, respectively, with the nonglycosylated forms showing intermediate stability depending on solution pH. In the aglycosylated Fc proteins, the introduction of Asp (D) residues at site 297 (QQ vs. DN vs. DD forms) resulted in more subtle changes in structural integrity and physical stability depending on solution pH. The utility of evaluating the conformational stability profile differences between the various IgG1-Fc glycoproteins is discussed in the context of analytical comparability studies.

摘要

测定了由毕赤酵母产生的具有不同糖基化位点占据情况(二糖基化、单糖基化和非糖基化)的各种IgG1-Fc蛋白的结构完整性和构象稳定性。此外,还研究了三种不同形式的非糖基化Fc分子(由于Fc糖型的点突变和酶切作用,CH2结构域中第297位氨基酸残基不同)的物理稳定性概况。通过使用多种技术结合数据可视化工具(三个指标的经验相图和雷达图)的高通量生物物理分析,研究了这些IgG1-Fc糖蛋白的物理稳定性随pH值和温度的变化情况。在4.0-6.0的pH范围内,IgG1-Fc的二糖基化和单糖基化形式分别表现出最高和最低的物理稳定性水平,非糖基化形式的稳定性则根据溶液pH值处于中间水平。在无糖基化的Fc蛋白中,第297位引入天冬氨酸(D)残基(QQ型与DN型与DD型)会导致结构完整性和物理稳定性根据溶液pH值发生更细微的变化。在分析可比性研究的背景下,讨论了评估各种IgG1-Fc糖蛋白之间构象稳定性概况差异的实用性。

相似文献

1
Physical stability comparisons of IgG1-Fc variants: effects of N-glycosylation site occupancy and Asp/Gln residues at site Asn 297.IgG1-Fc变体的物理稳定性比较:N-糖基化位点占据情况及Asn 297位点处Asp/Gln残基的影响
J Pharm Sci. 2014 Jun;103(6):1613-1627. doi: 10.1002/jps.23975. Epub 2014 Apr 16.
2
Correlating the Impact of Well-Defined Oligosaccharide Structures on Physical Stability Profiles of IgG1-Fc Glycoforms.明确的寡糖结构对IgG1-Fc糖型物理稳定性概况的影响相关性研究
J Pharm Sci. 2016 Feb;105(2):588-601. doi: 10.1016/j.xphs.2015.10.014. Epub 2015 Dec 30.
3
Production, Characterization, and Biological Evaluation of Well-Defined IgG1 Fc Glycoforms as a Model System for Biosimilarity Analysis.作为生物相似性分析模型系统的明确IgG1 Fc糖型的生产、表征及生物学评价
J Pharm Sci. 2016 Feb;105(2):559-574. doi: 10.1016/j.xphs.2015.11.003. Epub 2016 Jan 9.
4
Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.利用氢交换-质谱法研究糖基化对高纯度 IgG1-Fc 糖型局部骨架柔性的影响。
J Pharm Sci. 2018 Sep;107(9):2315-2324. doi: 10.1016/j.xphs.2018.04.026. Epub 2018 May 8.
5
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.人IgG-Fc糖型的结构分析揭示了糖基化与结构完整性之间的相关性。
J Mol Biol. 2003 Jan 31;325(5):979-89. doi: 10.1016/s0022-2836(02)01250-0.
6
High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.高通量生物物理分析和去糖基化后 IgG1 单克隆抗体构象稳定性的数据可视化。
J Pharm Sci. 2013 Nov;102(11):3942-56. doi: 10.1002/jps.23730. Epub 2013 Sep 24.
7
Effect of pH, temperature, and salt on the stability of Escherichia coli- and Chinese hamster ovary cell-derived IgG1 Fc.pH 值、温度和盐度对大肠杆菌和中国仓鼠卵巢细胞来源的 IgG1 Fc 稳定性的影响。
Biochemistry. 2012 Dec 18;51(50):10056-65. doi: 10.1021/bi300702e. Epub 2012 Dec 4.
8
Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors.对人IgG1多聚体和单体的可结晶片段(Fc)区域进行工程改造,以微调与唾液酸依赖性受体的相互作用。
J Biol Chem. 2017 Aug 4;292(31):12994-13007. doi: 10.1074/jbc.M117.795047. Epub 2017 Jun 15.
9
Comparative Evaluation of the Chemical Stability of 4 Well-Defined Immunoglobulin G1-Fc Glycoforms.4种明确的免疫球蛋白G1-Fc糖型化学稳定性的比较评估
J Pharm Sci. 2016 Feb;105(2):575-587. doi: 10.1016/j.xphs.2015.10.024. Epub 2016 Jan 11.
10
Site-specific glycosylation of an aglycosylated human IgG1-Fc antibody protein generates neoglycoproteins with enhanced function.去糖基化的人IgG1-Fc抗体蛋白的位点特异性糖基化产生具有增强功能的新糖蛋白。
Chem Biol. 2003 Sep;10(9):807-14. doi: 10.1016/j.chembiol.2003.08.006.

引用本文的文献

1
Strategies for the production of isotopically labelled Fab fragments of therapeutic antibodies in Komagataella phaffii (Pichia pastoris) and Escherichia coli for NMR studies.利用 Komagataella phaffii(毕赤酵母)和 Escherichia coli(大肠杆菌)生产治疗性抗体的同位素标记 Fab 片段用于 NMR 研究的策略。
PLoS One. 2023 Nov 29;18(11):e0294406. doi: 10.1371/journal.pone.0294406. eCollection 2023.
2
Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies.噬菌体展示生物淘选策略对抗细胞表面受体抗体的选择评估。
Int J Mol Sci. 2022 Jul 30;23(15):8470. doi: 10.3390/ijms23158470.
3
Process- and Product-Related Foulants in Virus Filtration.病毒过滤中与过程和产品相关的污染物
Bioengineering (Basel). 2022 Apr 4;9(4):155. doi: 10.3390/bioengineering9040155.
4
Fc Galactosylation Promotes Hexamerization of Human IgG1, Leading to Enhanced Classical Complement Activation.Fc 半乳糖基化促进人 IgG1 六聚体形成,导致经典补体激活增强。
J Immunol. 2021 Sep 15;207(6):1545-1554. doi: 10.4049/jimmunol.2100399. Epub 2021 Aug 18.
5
Solution structure of deglycosylated human IgG1 shows the role of C2 glycans in its conformation.去糖基化人 IgG1 的溶液结构显示了 C2 聚糖在其构象中的作用。
Biophys J. 2021 May 4;120(9):1814-1834. doi: 10.1016/j.bpj.2021.02.038. Epub 2021 Mar 4.
6
Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris.毕赤酵母中重组 N-糖基化蛋白的均相生产与表征。
Microb Cell Fact. 2020 Jan 13;19(1):7. doi: 10.1186/s12934-020-1280-0.
7
Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics.具有优化物理化学性质的Fc片段工程,意味着基于Fc的治疗药物临床潜力的提升。
Front Immunol. 2018 Jan 8;8:1860. doi: 10.3389/fimmu.2017.01860. eCollection 2017.
8
Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™.在压力下的生物相似性:利妥昔单抗和雷莫西尤单抗的强制降解研究。
MAbs. 2017 Oct;9(7):1197-1209. doi: 10.1080/19420862.2017.1347741. Epub 2017 Aug 8.
9
Assessment of Hepatocellular Carcinoma Metastasis Glycobiomarkers Using Advanced Quantitative N-glycoproteome Analysis.使用先进的定量N-糖蛋白质组分析评估肝细胞癌转移糖生物标志物
Front Physiol. 2017 Jul 7;8:472. doi: 10.3389/fphys.2017.00472. eCollection 2017.
10
Synthesis of a Bifunctional Peptide Inhibitor-IgG1 Fc Fusion That Suppresses Experimental Autoimmune Encephalomyelitis.一种抑制实验性自身免疫性脑脊髓炎的双功能肽抑制剂-IgG1 Fc融合蛋白的合成
Bioconjug Chem. 2017 Jul 19;28(7):1867-1877. doi: 10.1021/acs.bioconjchem.7b00175. Epub 2017 Jun 22.

本文引用的文献

1
High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.高通量生物物理分析和去糖基化后 IgG1 单克隆抗体构象稳定性的数据可视化。
J Pharm Sci. 2013 Nov;102(11):3942-56. doi: 10.1002/jps.23730. Epub 2013 Sep 24.
2
Antibodies to watch in 2013: Mid-year update.2013 年值得关注的抗体:年中更新。
MAbs. 2013 Jul-Aug;5(4):513-7. doi: 10.4161/mabs.24990. Epub 2013 May 9.
3
Physicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximab.在提议的生物类似药 GP2013 利妥昔单抗与原研药利妥昔单抗之间的理化性质和功能可比性。
BioDrugs. 2013 Oct;27(5):495-507. doi: 10.1007/s40259-013-0036-3.
4
Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen/deuterium-exchange mass spectrometry.用氘氢交换质谱法测量的局部动力学研究赋形剂对 IgG1 单克隆抗体构象和储存稳定性的影响。
J Pharm Sci. 2013 Jul;102(7):2136-51. doi: 10.1002/jps.23543. Epub 2013 Apr 25.
5
Effects of salts from the Hofmeister series on the conformational stability, aggregation propensity, and local flexibility of an IgG1 monoclonal antibody.Hofmeister 系列盐对 IgG1 单克隆抗体构象稳定性、聚集倾向和局部柔性的影响。
Biochemistry. 2013 May 14;52(19):3376-89. doi: 10.1021/bi400232p. Epub 2013 May 2.
6
Assessment of higher order structure comparability in therapeutic proteins using nuclear magnetic resonance spectroscopy.利用核磁共振光谱法评估治疗性蛋白质的高级结构可比性。
J Pharm Sci. 2013 Jun;102(6):1724-1733. doi: 10.1002/jps.23531. Epub 2013 Apr 9.
7
Glycoproteomic analysis of antibodies.糖蛋白质组学分析抗体。
Mol Cell Proteomics. 2013 Apr;12(4):856-65. doi: 10.1074/mcp.R112.026005. Epub 2013 Jan 16.
8
High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides.利用糖肽的质谱法进行高通量 IgG Fc N-糖基化分析。
J Proteome Res. 2013 Feb 1;12(2):821-31. doi: 10.1021/pr300887z. Epub 2013 Jan 18.
9
What's fueling the biotech engine-2011 to 2012.推动生物技术引擎发展的因素——2011年至2012年
Nat Biotechnol. 2012 Dec;30(12):1191-7. doi: 10.1038/nbt.2437.
10
Comparative signature diagrams to evaluate biophysical data for differences in protein structure across various formulations.比较特征图谱,评估不同制剂中蛋白质结构差异的生物物理数据。
J Pharm Sci. 2013 Jan;102(1):43-51. doi: 10.1002/jps.23367. Epub 2012 Nov 15.